CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd (CLGN) Historical Volatility
CLGN 30-day historical volatility is 117%. This ranks in the 68th percentile of readings over the past year.
Read more
Tracking CLGN historical volatility helps you see how much CollPlant Biotechnologies Ltd's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, CollPlant Biotechnologies Ltd's HV tells you what really happened. Use our scanner to monitor CLGN 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The CLGN 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing CollPlant Biotechnologies Ltd's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds.
It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts CollPlant Biotechnologies Ltd's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where CLGN HV is running hot, cold, or in line. Make the CLGN 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 23, 2026
As of September 23, 2026
See how volatility has moved over time
Track CLGN historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→